These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17926249)

  • 21. The effectiveness of walking in preventing cardiovascular disease in women: a review of the current literature.
    Albright C; Thompson DL
    J Womens Health (Larchmt); 2006 Apr; 15(3):271-80. PubMed ID: 16620186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triggers of acute myocardial infarction: a neglected piece of the puzzle.
    Colombo A; Proietti R; Culić V; Lipovetzky N; Viecca M; Danna P
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):1-7. PubMed ID: 24500234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel therapies for cardiometabolic risk reduction and implications for clinical practice.
    Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S37-42. PubMed ID: 17934393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes in primary care: protocol of a cluster randomised, controlled trial.
    Buhse S; Mühlhauser I; Kuniss N; Müller UA; Lehmann T; Liethmann K; Lenz M
    BMC Fam Pract; 2015 Mar; 16():43. PubMed ID: 25887378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the overestimation of the benefit of prevention].
    Mühlhauser I
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(4):208-18. PubMed ID: 24889710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and secondary prevention of cardiovascular disease in the elderly.
    García-Palmieri MR
    Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of diabetes: what can be done and how much can be prevented?
    Schulze MB; Hu FB
    Annu Rev Public Health; 2005; 26():445-67. PubMed ID: 15760297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes mellitus type 2].
    Hauner H; Scherbaum WA
    Dtsch Med Wochenschr; 2002 May; 127(19):1003-5. PubMed ID: 11997866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of cardiovascular disease].
    Rev Infirm; 2006 Mar; (119):16-23. PubMed ID: 16625779
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study.
    Lanas F; Avezum A; Bautista LE; Diaz R; Luna M; Islam S; Yusuf S;
    Circulation; 2007 Mar; 115(9):1067-74. PubMed ID: 17339564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical approach to reducing cardiovascular risk factors.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S25-36. PubMed ID: 17934391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential benefits of controlling coronary heart disease risk factors in the United Arab Emirates.
    Abdulle AM; Nagelkerke NJ; Abouchacra S; Obineche EN
    Kidney Blood Press Res; 2008; 31(3):185-8. PubMed ID: 18493155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing cardiovascular disease in Kentucky: epidemiology, trends, and strategies for the future.
    Rugg SS; Bailey AL; Browning SR
    J Ky Med Assoc; 2008 Apr; 106(4):149-61; quiz 149, 162-3. PubMed ID: 18478845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T
    Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular prevention (VI). Use of drugs in the primary prevention of arterial hypertension and dyslipidemia.
    González-Juanatey JR; Mazón Ramos P
    Rev Esp Cardiol; 2008 Aug; 61(8):861-79. PubMed ID: 18684369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis.
    Bohn B; Schöfl C; Zimmer V; Hummel M; Heise N; Siegel E; Karges W; Riedl M; Holl RW;
    Cardiovasc Diabetol; 2016 May; 15():72. PubMed ID: 27141979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary prevention in acute myocardial infarction].
    Ferreira R; Ferreira D; Correia MJ; De Sá ME; De Sousa JV; Sousa JV; Tavares MG
    Acta Med Port; 2001; 14(2):149-69. PubMed ID: 11475986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.